Pre-cancerous changes in urothelial endocytic vesicle leakage, fatty acid composition, and As and associated element concentrations after arsenic exposure

Toxicology

Volumn 284, Issue 1-3, 2011, Pages 26-33

  Grasso, E J ^a   Bongiovanni, G A ^b   Perez R D ^c   Calderon R O ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DEL COMAHUE   (Argentina)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Arsenic pre cancerous changes; Fatty acid composition; Leakage; SR XRF; Urothelial endocytic vesicles

Indexed keywords

ARSENIC; CALCIUM; COPPER; DRINKING WATER; IRON; POTASSIUM; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL STRUCTURE; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENVIRONMENTAL EXPOSURE; FLUORESCENCE ANALYSIS; INGESTION; LIPID COMPOSITION; MALE; NONHUMAN; PERMEABILITY BARRIER; PRECANCER; PRIORITY JOURNAL; RAT; SYNCHROTRON RADIATION X RAY FLUORESCENCE SPECTROMETRY; UROTHELIUM; X RAY FLUORESCENCE;

ANIMALS; ARSENIC; CELL MEMBRANE PERMEABILITY; FATTY ACIDS; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; TRANSPORT VESICLES; URINARY BLADDER; UROTHELIUM;

RATTUS;

EID: 79955467326     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2011.03.009     Document Type: Article

References (44)

1. Adair B.M., Moore T., Conklin S.D., Creed J.T., Wolf D.C., Thomas D.J. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats. Toxicol. Appl. Pharmacol. 2007, 222:235-242.
2. Aposhian H.V., Aposhian M.M. Arsenic toxicology: five questions. Chem. Res. Toxicol. 2006, 19(1):1-15.
3. Bates M.N., Smith A.H., Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 1992, 135:462-476.
4. Bongiovanni G.A., Eynard A.R., Calderón R.O. Altered lipid profile and changes in uroplakin properties of rat urothelial plasma membrane with diets of different lipid composition. Mol. Cell. Biochem. 2005, 271(1-2):69-75.
5. Calderon R.O., Eynard A.R. Fatty acids specifically related to anisotropic properties of plasma membranes from rat urothelium. Biochim. Biophys. Acta 2000, 1483:174-184.
6. Calderón R.O., Glocker M., Eynard A.R. Lipid and fatty acid composition of different fractions from rats urinary transitional epithelium. Lipids 1998, 33:1017-1022.
7. Calderon R.O., Grasso E.J. Symmetric array of the urothelium surface controlled by the lipid lattice composition. Biochim. Biophys. Res. Commun. 2006, 339:642-646.
8. Cantellops D., Reid A.P., Eitenmiller R.R., Long A.R. Determination of lipids in infant formula powder by direct extraction methylation of lipids and fatty acid methyl esters (FAME) analysis by gas chromatography. J. AOAC Int. 1999, 82:1128-1139.
9. Chang A., Hammond T.G., Sun T.T., Zeidel M.L. Permeability properties of the mammalian bladder apical membrane. Am. J. Physiol. 1994, 267:1483-1492.
10. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., Chen C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153(5):411-418.
11. Chu H.A., Crawford-Brown D.J. Inorganic arsenic in drinking water and bladder cancer: a meta-analysis for dose-response assessment. Int. J. Environ. Res. Public Health 2007, 3(4):316-322.
12. Cohen S.M. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol. Pathol. 2002, 30(6):663-671.
13. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 2006, 36:99-133.
14. Cohen S.M., Ohnishi T., Arnold L.L., Le X.C. Arsenic-induced bladder cancer in an animal model. Toxicol. Appl. Pharmacol. 2007, 222:258-263.
15. Dopp E., Hartmann L.M., Florea A.M., von Recklinghausen U., Pieper R., Shokouhi B., Rettenmeier A.W., Hirner A.V., Obe G. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol. Appl. Pharmacol. 2004, 201(2):156-165.
16. Dopp E., von Recklinghausen U., Díaz-Bone R., Hirner A.V., Rettenmeier A.W. Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells. Environ. Res. 2010, 110:435-442.
17. Eblin K.E., Bowen M.E., Cromey D.W., Bredfeldt T.G., Mash E.A., Lau S.S., Gandolfi A.J. Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicol. Appl. Pharmacol. 2006, 217(1):7-14.
18. Felipe A., Vicente R., Villalonga N., Roura-Ferrer M., Martínez-Mármol R., Solé L., Ferreres J.C., Condom E. Potassium channels: new targets in cancer therapy. Cancer Detect. Prev. 2006, 30(4):375-385.
19. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226(1):497-509.
20. Grasso E.J., Calderón R.O. Urinary bladder membrane permeability differentially induced by membrane lipid composition. Mol. Cell. Biochem. 2009, 330:163-169.
21. Grasso E.J., Calderón R.O. Endocytosis in urothelial umbrella cells: endocytic vesicles traffic. Endocytosis: Structural Components, Functions and Pathways 2010, 67-93. NovaScience Publishers, New York. C. Dowler Brynn (Ed.).
22. Heuvingh J., Bonneau S. Asymmetric oxidation of giant vesicles triggers curvature-associated shape transition and permeabilization. Biophys. J. 2009, 97(11):2904-2912.
23. Hicks R.M. The mammalian urinary bladder: an accommodating organ. Biol. Rev. Camb. Philos. Soc. 1975, 50:215-246.
24. Huang Y.L., Sheu J.Y., Lin T.H. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin. Biochem. 1999, 32(2):131-136.
25. Hunder G., Schaper J., Ademuyiwa O., Elsenhans B. Species differences in arsenic-mediated renal copper accumulation: a comparison between rats, mice and guinea pigs. Hum. Exp. Toxicol. 1999, 18(11):699-705.
26. Ladokhin A.S., Wimley W.C., White S.H. Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching. Biophys. J. 1995, 69:1964-1971.
27. Lakowicz J.R. Quenching of fluorescence. Principles of Fluorescence Spectroscopy 1983, 258-297. Plenum Press, New York. 1st ed. J.R. Lakowicz (Ed.).
28. Lewis S.A. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am. J. Physiol. 2000, 278:F867-F874.
29. Lewis S.A., de Moura J.L. Apical membrane area of rabbit urinary bladder increases by fusion of intracellular vesicle: an electrophysiological studies. J. Membr. Biol. 1984, 82:123-136.
30. Luster M.I., Simeonova P.P. Arsenic and urinary bladder cell proliferation. Toxicol. Appl. Pharmacol. 2004, 198(3):419-423.
31. Pérez C.A., Radtke M., Sánchez H.J., Tolentino H., Neuenshwander R.T., Barg W., Rubio M., Bueno M.I.S., Raimundo I.M., Rohwedder J.J.R. Synchrotron radiation X-ray fluorescence at the LNLS: beam line instrumentation and experiments. X-ray Spectrom. 1999, 28(5):320-326.
32. Rubatto Birri P.N., Pérez R.D., Cremonezzi D., Pérez C.A., Rubio M., Bongiovanni G.A. Association between As and Cu renal cortex accumulation and physiological and histological alterations after chronic arsenic intake. Environ. Res. 2010, 110:417-423.
33. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74(6):289-299.
34. Suzuki S., Arnold L.L., Ohnishi T., Cohen S.M. Effects of inorganic arsenic on the rat and mouse urinary bladder. Toxicol. Sci. 2008, 106(2):350-363.
35. Tapio S., Grosche B. Arsenic in the aetiology of cancer. Mut. Res. 2006, 612(3):215-246.
36. Truschel S.T., Wang E., Ruiz W.G., Leung S.M., Rojas R., Lavelle J., Zeidel M., Stoffer D., Apodaca G. Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol. Biol. Cell 2002, 13(3):830-846.
37. Tseng C.H. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J. Environ. Sci. Health C: Environ. Carcinog. Ecotoxicol. 2007, 25(1):1-22.
38. Vaughan W.M., Weber G. Oxygen quenching of pyrenebutyric acid fluorescence in water. A dynamic probe of the microenvironment. Biochemistry 1970, 9(3):464-473.
39. Wang J.P., Qi L., Moore M.R., Ng J.C. A review of animal models for the study or arsenic carcinogenesis. Toxicol. Lett. 2002, 133:17-31.
40. Wang T.C., Jan K.Y., Wang A.S., Gurr J.R. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mut. Res. 2007, 615(1-2):75-86.
41. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 2002, 23(8):1387-1397.
42. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 1995, 20(9):1873-1876.
43. Wimley W.C., Selsted M.E., White S.H. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci. 1994, 3(9):1362-1373.
44. Wu X.R., Medina J.J., Sun T.T. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single trnsmembrane-domained proteins in differentiated urothelial cells. J. Biol. Chem. 1995, 270(50):29752-29759.